It also has been shown that losartan ameliorates dystrophic epidermolysis bullosa in recessive dystrophic epidermolysis bullosa (RDEB) mice by reducing the TGF-β signaling and thus halting fibrosis. Here, TGFB1 is linked to recessive dystrophic epidermolysis bullosa.